Correction to “B-cell Maturation Antigen-Based Therapies Post-Talquetamab in Relapsed or Refractory Multiple Myeloma”

Abstract

Shrestha A, Alzubi M, Alrawabdeh J, Schinke C, Thanendrarajan S, Zangari M, et al. B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myeloma. eJHaem. 2024;5:554-59. doi:10.1002/jha2.896

Carolina Schinke has mistakenly not declared her Conflict of Interest and would like to add a sentence stating “CS has participated in Advisory Board Meetings of Janssen, Pfizer and Arcellx”.

We apologize for this error.